According to AquaBounty's latest financial reports the company has $16.76 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.10 B | -46.57% |
2021-12-31 | $0.19 B | 98.67% |
2020-12-31 | $95.75 M | 3321.22% |
2019-12-31 | $2.79 M | -6.79% |
2018-12-31 | $3 M | 493.06% |
2017-12-31 | $0.5 M | -84.82% |
2016-12-31 | $3.33 M | 151.95% |
2015-12-31 | $1.32 M | -74.42% |
2014-12-31 | $5.17 M | 173.96% |
2013-12-31 | $1.88 M | 420.54% |
2012-12-31 | $0.36 M | -77.94% |
2011-12-31 | $1.64 M | -73.43% |
2010-12-31 | $6.19 M | 8.77% |
2009-12-31 | $5.69 M | -46.06% |
2008-12-31 | $10.55 M | -37.3% |
2007-12-31 | $16.83 M | -28.02% |
2006-12-31 | $23.38 M | 9405.93% |
2005-12-31 | $0.24 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $5.29 M | -68.42% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.12 B | 647.97% | ๐ฌ๐ง UK |
Novavax NVAX | $0.56 B | 3,290.60% | ๐บ๐ธ USA |
Novocure
NVCR | $0.91 B | 5,330.97% | Jersey |